Literature DB >> 991090

Bone marrow manifestations of Hodgkin's disease.

D I O'Carroll, R W McKenna, R D Brunning.   

Abstract

Bone marrow trephine biopsies were performed on 107 previously untreated patients with Hodgkin's disease (HD). Fifteen patients (14%) exhibited bone marrow involvement. These consisted of two of three patients (67%) with lymphocyte depletion, six of 27 patients (22%) with mixed cellularity, five of 64 patients (8%) with nodular sclerosis, and two who were unclassified. Twelve patients manifested a diffuse pattern of involvement; three, a focal pattern. In eight patients more than 70% of the marrow biopsy was replaced by Hodgkin's tissue, in one patient 50% of the marrow biopsy was replaced, and in six patients less than 30% of the marrow biopsy was replaced. Typical Reed-Sternberg (RS) cells were found in the trephine biopsies in 13 of the 15 patients and mononuclear RS variants in two. Bone marrow involvement was the only evidence of stage IV disease in 10 of the 15 patients. In addition to the 15 patients with initial involvement with HD, 11 patients without marrow involvement exhibited granulomas (six) and benign lymphocytic aggregates (five) in their trephine sections. Hematological parameters were studied in all pretreatment patients. Only in the nodular sclerosis group were these parameters useful in differentiating patients with and without Hodgkin's involvement of the marrow. Seventeen additional patients who had been previously treated at the time HD was demonstrated in their bone marrow were also studied. Large areas of necrosis were frequently seen in previously treated patients and one patient demonstrated cryptococcosis in the bone marrow.

Entities:  

Mesh:

Year:  1976        PMID: 991090     DOI: 10.1002/1097-0142(197610)38:4<1717::aid-cncr2820380445>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Bone marrow trephine biopsy in lymphoproliferative disease.

Authors:  C Schmid; P G Isaacson
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

2.  Lymphadenopathy in a 20-year-old woman with mixed connective tissue disease.

Authors:  J M Zijlmans; P M Kluin; L J Schultze Kool; R Bieger
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

Review 3.  Differential diagnoses of bone marrow granuloma.

Authors:  A Eid; W Carion; J S Nystrom
Journal:  West J Med       Date:  1996-06

Review 4.  Granulomatous reactions cause symptoms or clinically imitate treatment resistance in small lymphocytic lymphoma/chronic lymphocytic leukaemia more frequently than in other non-Hodgkin lymphomas.

Authors:  A Brunner; J Kantner; A Tzankov
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

5.  Features and prognosis of chemotherapy-treated Hodgkin's disease with initial bone marrow involvement.

Authors:  G Auclerc; M F Auclerc; M Weil; J M Andrieu; C Jacquillat; J Bernard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  A young man with fever, splenomegaly, hepatic granulomas, and lymphocytic bone marrow infiltrates.

Authors:  P P Tak; P M Kluin; J A Hoogkamp-Korstanje; J de Koning; R Bieger; J C Kluin-Nelemans
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

7.  Lymphoproliferations in the bone marrow: identification and evolution, classification and staging.

Authors:  R Bartl; B Frisch; R Burkhardt; K Jäger; R Pappenberger; G Hoffmann-Fezer
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

8.  Angioimmunoblastic lymphadenopathy. Histopathology of bone marrow involvement.

Authors:  U Schnaidt; K F Vykoupil; J Thiele; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

9.  Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET-CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin Lymphoma.

Authors:  Mesut Göçer; Erdal Kurtoğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2020-05-04       Impact factor: 0.900

10.  Hodgkin's disease diagnosed post mortem: a population based study.

Authors:  H Hasle; A Mellemgaard
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.